AEterna Zentaris Inc. (NASDAQ: AEZS) today announced that Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), its partner and licensee ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE